Clinical Trial Update: A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver [Phase 4]

View source ↗

Summary

A Phase IV trial of Huazhi Rougan Granule for non-alcoholic simple fatty liver has completed, assessing efficacy and safety in real-world use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Huazhi Rougan Granule

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Efficacy and Safety | Phase 4 | Status: COMPLETED